Vip Pharmaceuticals Private Limited

Produces pharmaceuticals, medicines, chemicals, and botanical products such as capsules, tablets, and ointments.

2000 | Delhi (India) | Active
Last Updated: January 03, 2025

Vip Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.90 M
  • Company Age 24 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.99 Cr
  • Satisfied Charges ₹ 1.13 Cr
  • Revenue Growth -12.55%
  • Profit Growth 0.68%
  • Ebitda -21.25%
  • Net Worth 27.98%
  • Total Assets 23.11%

About Vip Pharmaceuticals

Vip Pharmaceuticals Private Limited (VPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 September 2000 and has a history of 24 years and four months. Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.

The company currently has active open charges totaling ₹2.99 Cr. The company has closed loans amounting to ₹1.13 Cr, as per Ministry of Corporate Affairs (MCA) records.

Deepak Kumar and Naresh Kumar serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    vippharma.co.in

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239DL2000PTC107962

  • Company No.

    107962

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    29 Sep 2000

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Vip Pharmaceuticals Private Limited offer?

Vip Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Allopathic Cough Syrup, Respiratory System Drugs, Anti Asthma Drug, Cough Syrup, Antihistamines, Dexchlorpheniramine Maleate Tablet, Nervous System and Antipsychotic API.

Who are the key members and board of directors at Vip Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Deepak Kumar Country flag representing In Director 01-Sep-2022Current
Naresh Kumar Country flag representing In Additional Director 01-Jan-2023Current

Financial Performance of Vip Pharmaceuticals.

Vip Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.55% decrease. The company also saw a slight improvement in profitability, with a 0.68% increase in profit. The company's net worth Soared by an impressive increase of 27.98%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-12.55%
Revenue from Operations
-13.55%
Total Assets
23.11%
Profit or Loss
0.68%
Net Worth
27.98%
EBITDA
-21.25%

What is the Ownership and Shareholding Structure of Vip Pharmaceuticals?

In 2020, Vip Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹29.85 M

Satisfied Charges

₹11.25 M

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 2.99 Cr

Latest Charge Details

DateLenderAmountStatus
16 Apr 2022Hdfc Bank Limited₹2.99 CrOpen
19 Feb 2015Vijaya Bank₹6.00 MSatisfied
14 Aug 2007Vijay Bank₹3.00 MSatisfied
07 Apr 2006Vijay Bank₹1.40 MSatisfied
06 Mar 2001Bank Of Baroda₹0.85 MSatisfied

How Many Employees Work at Vip Pharmaceuticals?

Vip Pharmaceuticals has a workforce of 21 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vip Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vip Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Vip Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Vip Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Vip Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

    31 Mar 2024

  • Director Appointment

    Naresh Kumar was appointed as a Additional Director was appointed as a Additional Director on 01 Jan 2023 & has been associated with this company since 2 years 1 month .

    01 Jan 2023

  • Director Appointment

    Deepak Kumar was appointed as a Director was appointed as a Director on 01 Sep 2022 & has been associated with this company since 2 years 5 months .

    01 Sep 2022

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 29.85 M with Charge ID 100560181 was registered on 16 Apr 2022.

    16 Apr 2022

  • Charges

    A charge registered on 06 Mar 2001 via Charge ID 90048372 with Bank Of Baroda was fully satisfied on 28 Jun 2021.

    28 Jun 2021

Frequently asked questions

  • Vip Pharmaceuticals Private Limited was incorporated on 29 Sep 2000.

  • The authorized share capital of Vip Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.90 M.

  • Currently 2 directors are associated with Vip Pharmaceuticals Private Limited.

    • Deepak Kumar
    • Naresh Kumar
  • As per Ministry of Corporate Affairs (Mca), the registered address of Vip Pharmaceuticals Private Limited is B 6 7Gali No 13 Madhu Vihar India, New Delhi, 110002.

  • The corporate identification number (CIN) of Vip Pharmaceuticals Private Limited is U24239DL2000PTC107962 and the company number is 107962 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Vip Pharmaceuticals Private Limited is https://www.vippharma.co.in

  • According to the financial reports for the fiscal year 2020, the revenue trend for Vip Pharmaceuticals Private Limited has fallen by -12.55%.

  • As Per 2020 financial reports, 21 employees are currently employed by Vip Pharmaceuticals Private Limited.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Vip Pharmaceuticals Private Limited has experienced an upsurge of 27.98%.

  • As per the financial statements for fiscal Year 2020, The total open charges for Vip Pharmaceuticals Private Limited amount to ₹ 2.99 Cr.

  • The most recent Balance Sheet for Vip Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development